Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs ALEMBIC PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB ALEMBIC PHARMA UNICHEM LAB/
ALEMBIC PHARMA
 
P/E (TTM) x 239.7 32.1 746.1% View Chart
P/BV x 1.4 4.4 32.7% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 UNICHEM LAB   ALEMBIC PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-23
ALEMBIC PHARMA
Mar-23
UNICHEM LAB/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs467792 58.9%   
Low Rs226463 48.8%   
Sales per share (Unadj.) Rs190.7287.6 66.3%  
Earnings per share (Unadj.) Rs-28.717.4 -165.1%  
Cash flow per share (Unadj.) Rs-12.631.4 -40.1%  
Dividends per share (Unadj.) Rs08.00 0.0%  
Avg Dividend yield %01.3 0.0%  
Book value per share (Unadj.) Rs344.2222.3 154.8%  
Shares outstanding (eoy) m70.41196.56 35.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.82.2 83.2%   
Avg P/E ratio x-12.136.1 -33.4%  
P/CF ratio (eoy) x-27.520.0 -137.5%  
Price / Book Value ratio x1.02.8 35.7%  
Dividend payout %046.0 -0.0%   
Avg Mkt Cap Rs m24,396123,402 19.8%   
No. of employees `000NANA-   
Total wages/salary Rs m3,56411,691 30.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m13,43056,526 23.8%  
Other income Rs m38530 1,266.9%   
Total revenues Rs m13,81556,557 24.4%   
Gross profit Rs m-8416,772 -12.4%  
Depreciation Rs m1,1342,754 41.2%   
Interest Rs m173502 34.5%   
Profit before tax Rs m-1,7643,546 -49.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m259126 205.1%   
Profit after tax Rs m-2,0223,420 -59.1%  
Gross profit margin %-6.312.0 -52.3%  
Effective tax rate %-14.73.6 -412.4%   
Net profit margin %-15.16.1 -248.9%  
BALANCE SHEET DATA
Current assets Rs m15,88529,139 54.5%   
Current liabilities Rs m6,39616,408 39.0%   
Net working cap to sales %70.722.5 313.7%  
Current ratio x2.51.8 139.8%  
Inventory Days Days5110 528.6%  
Debtors Days Days1,6007 23,675.6%  
Net fixed assets Rs m15,91131,498 50.5%   
Share capital Rs m141393 35.8%   
"Free" reserves Rs m24,09243,312 55.6%   
Net worth Rs m24,23343,705 55.4%   
Long term debt Rs m6360-   
Total assets Rs m31,82960,637 52.5%  
Interest coverage x-9.28.1 -113.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.40.9 45.3%   
Return on assets %-5.86.5 -89.8%  
Return on equity %-8.37.8 -106.6%  
Return on capital %-6.49.3 -69.1%  
Exports to sales %69.746.4 150.4%   
Imports to sales %12.412.1 102.6%   
Exports (fob) Rs m9,36626,210 35.7%   
Imports (cif) Rs m1,6696,846 24.4%   
Fx inflow Rs m9,36626,210 35.7%   
Fx outflow Rs m1,6696,846 24.4%   
Net fx Rs m7,69719,364 39.7%   
CASH FLOW
From Operations Rs m-8517,240 -11.8%  
From Investments Rs m2,028-4,476 -45.3%  
From Financial Activity Rs m-813-2,620 31.0%  
Net Cashflow Rs m746144 518.1%  

Share Holding

Indian Promoters % 70.2 69.1 101.6%  
Foreign collaborators % 0.0 0.5 -  
Indian inst/Mut Fund % 11.3 19.0 59.5%  
FIIs % 0.8 4.5 18.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.8 30.4 98.0%  
Shareholders   20,877 85,212 24.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Unichem Lab vs ALEMBIC PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Unichem Lab vs ALEMBIC PHARMA Share Price Performance

Period Unichem Lab ALEMBIC PHARMA S&P BSE HEALTHCARE
1-Day 3.46% -0.45% 1.18%
1-Month -3.95% -4.58% -0.75%
1-Year 80.86% 104.81% 61.82%
3-Year CAGR 16.65% 0.79% 18.16%
5-Year CAGR 20.24% 13.50% 19.79%

* Compound Annual Growth Rate

Here are more details on the Unichem Lab share price and the ALEMBIC PHARMA share price.

Moving on to shareholding structures...

The promoters of Unichem Lab hold a 70.2% stake in the company. In case of ALEMBIC PHARMA the stake stands at 69.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Unichem Lab and the shareholding pattern of ALEMBIC PHARMA.

Finally, a word on dividends...

In the most recent financial year, Unichem Lab paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

ALEMBIC PHARMA paid Rs 8.0, and its dividend payout ratio stood at 46.0%.

You may visit here to review the dividend history of Unichem Lab, and the dividend history of ALEMBIC PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.